Replies to post #13278 on BioCurex, Inc.(fka BOCX)

[doggone01]

I'm sure their will be a announement as all the companys I have been invested with have announced clinical trials,and its a positive for stock price.If we get the new license as well,we could break $1.00!

[Ted F]

I would think that Dr. Moro would be anxious to announce the start of any clinical trial so that he could raise some money via a private placement.

[Ted F]

After rereading that article, I think Dr. Moro was counting on going to trials with Abbott. If that's the case, did they ever pull the rug out from under his feet with the return. Let's hope he was talking about someone else.

PS-I wonder how IMA has viewed and responded to the "renogotiation" with ABT. It would be interesting to know just how involved they still are.

[HALF FULL GLASS]

Key words below "leading Institution" and "Radiologists"

I have a difficult time seeing this as Abbott.

"According to the researcher who discovered the RECAF marker, Ricardo Moro-Vidal, M.D., CEO and president, the company is gearing up to begin a clinical trial with a leading institution to determine if a blood test can help radiologists better anticipate if a lesion is benign or malignant.

This looks more like Goshen to me.